Related Articles
Shikonin inhibits the Warburg effect, cell proliferation, invasion and migration by downregulating PFKFB2 expression in lung cancer
Shikonin attenuates H<sub>2</sub>O<sub>2</sub>‑induced oxidative injury in HT29 cells via antioxidant activities and the inhibition of mitochondrial pathway‑mediated apoptosis
Shikonin induces apoptosis and G0/G1 phase arrest of gallbladder cancer cells via the JNK signaling pathway
Shikonin sensitizes wild‑type EGFR NSCLC cells to erlotinib and gefitinib therapy
Shikonin reduces endometriosis by inhibiting RANTES secretion and mononuclear macrophage chemotaxis